| 000 | 01673 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517164123.0 | ||
| 264 | 0 | _c20180514 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1542-233X | ||
| 024 | 7 |
_a10.1097/ICL.0000000000000414 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKovalchin, Joseph | |
| 245 | 0 | 0 |
_aPreclinical Development of EBI-005: An IL-1 Receptor-1 Inhibitor for the Topical Ocular Treatment of Ocular Surface Inflammatory Diseases. _h[electronic resource] |
| 260 |
_bEye & contact lens _cMay 2018 |
||
| 300 |
_a170-181 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xdrug therapy |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDry Eye Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 |
_aImmunoglobulin M _xanalysis |
| 650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOphthalmic Solutions _xtherapeutic use |
| 650 | 0 | 4 |
_aProteins _ximmunology |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aReceptors, Interleukin-1 _xantagonists & inhibitors |
| 700 | 1 | _aKing, Bracken | |
| 700 | 1 | _aMasci, Allyson | |
| 700 | 1 | _aHopkins, Elizabeth | |
| 700 | 1 | _aFry, Jeremy | |
| 700 | 1 | _aHou, Jay | |
| 700 | 1 | _aLi, Christian | |
| 700 | 1 | _aTenneson, Kelly | |
| 700 | 1 | _aWeber, Steve | |
| 700 | 1 | _aWolfe, Gary | |
| 700 | 1 | _aCollins, Kathy | |
| 700 | 1 | _aFurfine, Eric S | |
| 773 | 0 |
_tEye & contact lens _gvol. 44 _gno. 3 _gp. 170-181 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ICL.0000000000000414 _zAvailable from publisher's website |
| 999 |
_c27386832 _d27386832 |
||